{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:51Z","timestamp":1707523971735},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,2]]},"DOI":"10.7759\/cureus.44567","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T13:53:25Z","timestamp":1693662805000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Asymptomatic Severe Hypertriglyceridemia With Oral Therapy Only: A Case Study Shedding Light on Treatment Approaches and Potential Complications"],"prefix":"10.7759","author":[{"given":"Md","family":"Bhuiyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orin","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz","family":"Badar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha V","year":"2020","unstructured":"Simha V. Management of hypertriglyceridemia. BMJ. 2020, 371:m3109. 10.1136\/bmj.m3109","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund L","year":"2012","unstructured":"Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012, 97:2969-89. 10.1210\/jc.2011-3213","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","article-title":"Hypertriglyceridemia Management According to the 2018 AHA\/ACC Guideline: American College of Cardiology","author":"Jacobsen A","unstructured":"Jacobsen A, Savji N, Blumenthal R, Martin S. Hypertriglyceridemia Management According to the 2018 AHA\/ACC Guideline: American College of Cardiology. American College of Cardiology, Washington, DC;"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01488-8","article-title":"The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis","volume":"20","author":"Sanchez RJ","year":"2021","unstructured":"Sanchez RJ, Ge W, Wei W, Ponda MP, Rosenson RS. The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis. Lipids Health Dis. 2021, 20:72. 10.1186\/s12944-021-01488-8","journal-title":"Lipids Health Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6273196","article-title":"Triglyceride levels greater than 10,000 mg\/dL in a 49-year-old female without evidence of pancreatitis","volume":"2019","author":"Toor A","year":"2019","unstructured":"Toor A, Toor A, Khalighi K, Krishnamurthy M. Triglyceride levels greater than 10,000 mg\/dL in a 49-year-old female without evidence of pancreatitis. Case Rep Endocrinol. 2019, 2019:6273196. 10.1155\/2019\/6273196","journal-title":"Case Rep Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.995","article-title":"Management of severe hypertriglyceridemia in the hospital: a review","volume":"7","author":"Schaefer EW","year":"2012","unstructured":"Schaefer EW, Leung A, Kravarusic J, Stone NJ. Management of severe hypertriglyceridemia in the hospital: a review. J Hosp Med. 2012, 7:431-8. 10.1002\/jhm.995","journal-title":"J Hosp Med"},{"key":"ref7","article-title":"A rare case of severe hypertriglyceridemia in a patient with no acute pancreatitis after previous bouts of pancreatitis secondary to hypertriglyceridemia","volume":"23","author":"Guerriero T","year":"2022","unstructured":"Guerriero T, James C. A rare case of severe hypertriglyceridemia in a patient with no acute pancreatitis after previous bouts of pancreatitis secondary to hypertriglyceridemia. J Clin Transl Endocrinol. 2022, 23:100102.","journal-title":"J Clin Transl Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.1482","article-title":"SAT-577 severe asymptomatic hypertriglyceridemia","volume":"4","author":"Rodriguez D","year":"2020","unstructured":"Rodriguez D, Drame A. SAT-577 severe asymptomatic hypertriglyceridemia. J Endocr Soc. 2020, 4:SAT-577. 10.1210\/jendso\/bvaa046.1482","journal-title":"J Endocr Soc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SAT-084","article-title":"SAT-084 extremely severe asymptomatic hypertriglyceridemia: a rare case report","volume":"3","author":"Toor A","year":"2019","unstructured":"Toor A, Toor A, Khalighi K, Krishnamurthy M. SAT-084 extremely severe asymptomatic hypertriglyceridemia: a rare case report. J Endocr Soc. 2019, 3:SAT-084. 10.1210\/js.2019-SAT-084","journal-title":"J Endocr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.654","article-title":"Asymptomatic severe hypertriglyceridemia: reaching a new threshold","volume":"160","author":"Roadcloud E","year":"2021","unstructured":"Roadcloud E, Can A. Asymptomatic severe hypertriglyceridemia: reaching a new threshold. Chest. 2021, 160:A690. 10.1016\/j.chest.2021.07.654","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12925","article-title":"Conservative management in hypertriglyceridemia-associated pancreatitis","volume":"286","author":"Berberich AJ","year":"2019","unstructured":"Berberich AJ, Ziada A, Zou GY, Hegele RA. Conservative management in hypertriglyceridemia-associated pancreatitis. J Intern Med. 2019, 286:644-50. 10.1111\/joim.12925","journal-title":"J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani SS","year":"2021","unstructured":"Virani SS, Morris PB, Agarwala A, et al.. 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021, 78:960-93. 10.1016\/j.jacc.2021.06.011","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/170851-management-of-asymptomatic-severe-hypertriglyceridemia-with-oral-therapy-only-a-case-study-shedding-light-on-treatment-approaches-and-potential-complications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:54Z","timestamp":1707508614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/170851-management-of-asymptomatic-severe-hypertriglyceridemia-with-oral-therapy-only-a-case-study-shedding-light-on-treatment-approaches-and-potential-complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.44567","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,2]]}}}